American Life Science Pharmaceuticals, Inc. (ALSP Inc.) is a privately held company based in San Diego, California, specializing in the development of small molecule drugs for the treatment of neurodegenerative diseases, with a primary focus on traumatic brain injury (TBI). Their innovative approach aims to inhibit the enzymes responsible for the pathology associated with TBI, potentially offering a groundbreaking solution to this debilitating condition.
With a mission to address the significant impact of TBI on individuals' productivity and quality of life, ALSP Inc. is advancing a proprietary compound that prevents the activation of the inflammasome, a key factor in brain lesions caused by traumatic injury. By working closely with the FDA and employing a novel clinical strategy, they aim to achieve accelerated approval for their drug, potentially becoming the first approved treatment for TBI and paving the way for future advancements in the field of neurodegeneration.
Generated from the website